title: Antiretroviral agents used by HIV-uninfected persons for prevention: pre- and postexposure prophylaxis.
abstract: Prophylactic use of antimicrobial agents and microbicides has been proven for many infections, including surgical, gastrointestinal, upper respiratory, and meningococcal infections. Antiretroviral therapy for pregnant women prevents mother-to-child transmission of human immunodeficiency virus (HIV), which has become rare in settings where access to therapy is widespread. Postexposure prophylaxis after needlestick injury or significant sexual exposure is recommended on the basis of animal studies and case-control observational studies, although use of these interventions is limited to those who recognize exposure, have access, and have the power to use the interventions. Clinical trials are evaluating whether regular or preexposure use of antiretroviral therapy provides additional protection for persons at high risk of infection who are also offered standard prevention care, including HIV testing, counseling, condoms, and management of sexually transmitted infections. Trials are evaluating topical or oral use. Concerns have arisen with regard to optimal dosing strategies, costs, access, drug resistance, risk behavior, and the role of communities. Future implementation, if warranted, will be guided by the results of clinical trials in progress and engagement of communities exposed to HIV.
authors.affiliation: Gladstone Institute of Virology and Immunology and University of California, San Francisco, USA. robert.grant@ucsf.edu
authors.forename: Robert M
authors.initials: RM
authors.lastname: Grant
mesh_terms: D044966:Anti-Retroviral Agents / Q000627:therapeutic use*; D018890:Chemoprevention / Q000379:methods*; D005260:Female; D015658:HIV Infections / Q000517:prevention & control*; D006801:Humans; D018445:Infectious Disease Transmission, Vertical / Q000517:prevention & control; D008297:Male; D009784:Occupational Diseases / Q000517:prevention & control; D016273:Occupational Exposure; D011247:Pregnancy
chemical_list: D044966:Anti-Retroviral Agents
references.citation: J Acquir Immune Defic Syndr. 2004 Apr 15;35(5):519-25
references.pmid: 15021317
references.citation: J Exp Med. 2007 Apr 16;204(4):705-14
references.pmid: 17389241
references.citation: BMJ. 2006 Mar 11;332(7541):605-7
references.pmid: 16528088
references.citation: Lancet. 2007 Feb 24;369(9562):657-66
references.pmid: 17321311
references.citation: Clin Infect Dis. 2005 Oct 1;41(7):1035-40
references.pmid: 16142671
references.citation: Clin Infect Dis. 2006 Oct 1;43(7):904-10
references.pmid: 16941375
references.citation: Clin Infect Dis. 2005 Nov 15;41(10):1507-13
references.pmid: 16231265
references.citation: Surg Infect (Larchmt). 2006;7 Suppl 2:S37-9
references.pmid: 16895502
references.citation: PLoS Med. 2005 Sep;2(9):e234
references.pmid: 16008507
references.citation: Lancet. 1999 Mar 6;353(9155):773-80
references.pmid: 10459957
references.citation: AIDS. 2003 Apr 11;17(6):937-8
references.pmid: 12660549
references.citation: Science. 2005 Sep 30;309(5744):2170-1
references.pmid: 16195446
references.citation: J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Dec 1;16(4):266-71
references.pmid: 9402073
references.citation: Lancet. 2008 Jun 21;371(9630):2109-19
references.pmid: 18572080
references.citation: AIDS. 2005 Nov 4;19(16):1865-75
references.pmid: 16227795
references.citation: N Engl J Med. 1994 Nov 3;331(18):1173-80
references.pmid: 7935654
references.citation: J Infect Dis. 2001 Mar 1;183(5):707-14
references.pmid: 11181146
references.citation: MMWR Recomm Rep. 2005 Jan 21;54(RR-2):1-20
references.pmid: 15660015
references.citation: J Gen Intern Med. 2007 Jul;22(7):1003-6
references.pmid: 17390095
references.citation: J Acquir Immune Defic Syndr. 2008 Feb 1;47(2):241-7
references.pmid: 18340656
references.citation: Nat Med. 1996 Oct;2(10):1084-9
references.pmid: 8837605
references.citation: PLoS Clin Trials. 2007 May 25;2(5):e27
references.pmid: 17525796
references.citation: PLoS Med. 2008 Jan 15;5(1):e16
references.pmid: 18198941
references.citation: PLoS One. 2007 Sep 19;2(9):e875
references.pmid: 17878928
references.citation: Lancet. 1999 Mar 6;353(9155):781-5
references.pmid: 10459958
references.citation: PLoS Med. 2008 Feb;5(2):e28
references.pmid: 18254653
references.citation: Science. 1995 Nov 17;270(5239):1197-9
references.pmid: 7502044
references.citation: AIDS. 2004 Mar 26;18(5):787-92
references.pmid: 15075514
references.citation: Cochrane Database Syst Rev. 2009 Jan 21;(1):CD006734
references.pmid: 19160297
references.citation: Clin Infect Dis. 2009 Mar 15;48(6):806-15
references.pmid: 19193111
references.citation: J Acquir Immune Defic Syndr. 2009 Jan 1;50(1):77-83
references.pmid: 19295337
references.citation: Lancet. 1999 Sep 4;354(9181):795-802
references.pmid: 10485720
references.citation: Lancet. 1991 Feb 2;337(8736):253-60
references.pmid: 1671109
references.citation: Clin Infect Dis. 2004 Oct 15;39(8):1190-8
references.pmid: 15486844
references.citation: J Infect Dis. 2003 Mar 1;187(5):725-35
references.pmid: 12599045
references.citation: PLoS Med. 2005 Nov;2(11):e298
references.pmid: 16231970
references.citation: J Virol. 2000 Feb;74(4):1767-74
references.pmid: 10644348
references.citation: J Acquir Immune Defic Syndr. 2005 May 1;39(1):90-101
references.pmid: 15851919
references.citation: AIDS. 2001 Oct 19;15(15):1951-7
references.pmid: 11600822
references.citation: Cochrane Database Syst Rev. 2007 Jan 24;(1):CD003510
references.pmid: 17253490
references.citation: J Acquir Immune Defic Syndr. 2008 Apr 1;47(4):494-9
references.pmid: 18176318
references.citation: BMC Int Health Hum Rights. 2005 Aug 24;5:6
references.pmid: 16120208
references.citation: Lancet. 2002 Apr 6;359(9313):1178-86
references.pmid: 11955535
references.citation: Lancet. 2007 Feb 24;369(9562):643-56
references.pmid: 17321310
references.citation: J Infect Dis. 2001 Aug 15;184(4):429-38
references.pmid: 11471100
references.citation: Lancet. 2003 Oct 11;362(9391):1171-7
references.pmid: 14568737
references.citation: Lancet. 2008 Dec 6;372(9654):1977-87
references.pmid: 19059048
references.citation: Lancet. 1999 Mar 6;353(9155):786-92
references.pmid: 10459959